Vontobel Holding’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$88.1K Buy
30,787
+5,787
+23% +$17.8K ﹤0.01% 1429
2026
Q2
$76K Buy
25,000
+5,000
+25% +$14.9K ﹤0.01% 1425
2026
Q1
$61.6K Buy
20,000
+5,000
+33% +$21.2K ﹤0.01% 1172
2025
Q4
$54.2K Buy
+15,000
New +$65.4K ﹤0.01% 1402
2024
Q1
– Sell
-20,800
Closed -$234K – 1089
2023
Q4
$234K Buy
+20,800
New +$86.8K ﹤0.01% 989

Other funds holding ALT

Vontobel Holding's ALT Position: Q3 2026 in Review

Vontobel Holding increased its Altimmune (ALT) stake by 23% in Q3 2026, buying an estimated $17.8K and bringing the position to 30,787 shares worth $88.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Vontobel Holding first reported a position in ALT in Q4 2023 and has held it in 5 quarters since. The position peaked at $234K in Q4 2023. 127 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Vontobel Holding held 30,787 shares of Altimmune worth $88.1K as of Q3 2026.
  • Vontobel Holding bought 5,787 Altimmune shares in Q3 2026, an estimated $17.8K.
  • Altimmune made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1429 holding.
  • Vontobel Holding first reported a position in Altimmune in Q4 2023 and has held it in 5 quarters since.
  • Vontobel Holding's Altimmune position peaked at $234K in Q4 2023.
  • 127 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.